您的位置: 首页 > 农业专利 > 详情页

FAMILLE DES MIARN-212/132 COMME CIBLE THERAPEUTIQUE
专利权人:
MEDIZINISCHE HOCHSCHULE HANNOVER;MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
发明人:
THUM, THOMAS,CHOWDHURY, KAMAL,UCAR, AHMET,GUPTA, SHASHI KUMAR
申请号:
CA2847726
公开号:
CA2847726A1
申请日:
2012.09.06
申请国别(地区):
CA
年份:
2013
代理人:
摘要:
The present invention refers to inhibitors of microRNAs, particularly of microRNAs miR-212 and/or miR-132 for use in medicine, particularly in the diagnosis, treatment or prevention of cardiac disorders, e.g. cardiac hypertrophy-associated or autophagic disorders, and further refers to isolated nucleic acid molecules, particularly microRNAs miR-212 and/or miR-132 and related sequences, for use in medicine, particularly human medicine, more particularly in the diagnosis, treatment or prevention of disorders involving cardiac atrophy and/or dysfunctional autophagy, e.g. cardiac cachexia.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充